Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × Axitinib × Clear all

NCT04010071 2023-03-29

Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms, Liver Neoplasms